CEMP - Cempra, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
2.325
+0.025 (+1.087%)
As of 4:00PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.300
Open2.250
Bid0.000 x 0
Ask0.000 x 0
Day's Range2.200 - 2.350
52 Week Range2.050 - 7.400
Volume511,621
Avg. Volume951,144
Market Cap24.418M
Beta0.45
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Why Earnings Season Could Be Great for Cempra (MLNT)
    Zacks23 days ago

    Why Earnings Season Could Be Great for Cempra (MLNT)

    Cempra (MLNT) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

  • American City Business Journalslast month

    As merger closes, Cempra now trading as Melinta

    Following a shareholder vote Friday , Chapel Hill-based Cempra and New Haven, Connecticut-based Melinta have completed their merger. "This seems to be inauspicious start to a critically important enterprise," said Steve Brozak, managing partner and president of WBB Securities, following news of the shareholder vote.

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
    Capital Cubelast month

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc. and Emergent BioSolutions Inc. (JNJ-US, INVA-US and EBS-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)

  • American City Business Journalslast month

    How Cempra’s shareholder vote on Melinta merger shook out

    Chapel Hill-based Cempra (CEMP) held its 2017 stockholders meeting Friday. On the agenda: the company’s planned merger with New Haven, Connecticut-based Melinta Therapeutics . Following the meeting, Cempra announced that, while a number of merger-related proposals were approved, there were two that were not.

  • Is It The Right Time To Buy Cempra Inc (CEMP)?
    Simply Wall St.last month

    Is It The Right Time To Buy Cempra Inc (CEMP)?

    Cempra Inc (NASDAQ:CEMP), a pharmaceuticals company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGS, rising to the highs of $3.85Read More...

  • American City Business Journalslast month

    New CEO in place for Cempra, Melinta combination

    Wechsler will join the combined company from New York-based private equity firm Welsh, Carson, Anderson & Stowe, which he joined last year after serving as president and CEO of Smile Brands before it was sold.

  • What You Must Know About Cempra Inc’s (CEMP) Financial Strength
    Simply Wall St.2 months ago

    What You Must Know About Cempra Inc’s (CEMP) Financial Strength

    Investors are always looking for growth in small-cap stocks like Cempra Inc (NASDAQ:CEMP), with a market cap of USD $111.58M. However, an important fact which most ignore is: how financiallyRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Cempra, Inc. : October 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • 3 Companies Tackling the Antibiotic-Resistant Bacteria Crisis
    Motley Fool2 months ago

    3 Companies Tackling the Antibiotic-Resistant Bacteria Crisis

    Paratek Corp., Nabriva Therapeutics, and Cempra all appear on course to bring new antibiotics to market soon. But which could be the best bet for your portfolio now?

  • Capital Cube2 months ago

    ETFs with exposure to Cempra, Inc. : October 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Cempra, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Cempra, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube4 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson, Innoviva, Inc., NovaBay Pharmaceuticals, Inc., Emergent BioSolutions Inc. and Altimmune, Inc. (JNJ-US, INVA-US, NBY-US, EBS-US and ALT-US) that have also reported for this ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of CEMP earnings conference call or presentation 9-Aug-17 12:45pm GMT

    Q2 2017 Cempra Inc Earnings and Update on the Merger with Melinta Therapeutics Inc Call

  • Associated Press4 months ago

    Cempra reports 2Q loss

    The Chapel Hill, North Carolina-based company said it had a loss of 23 cents per share. The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment ...

  • TheStreet.com4 months ago

    These Two Biotech Stocks Are Going Berserk on Wednesday

    And then there is Mylan.

  • Capital Cube6 months ago

    ETFs with exposure to Cempra, Inc. : June 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Cempra, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to Cempra, Inc. : May 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cempra, Inc. Here are 5 ETFs with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Cempra, Inc. :CEMP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
    Capital Cube7 months ago

    Cempra, Inc. :CEMP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Cempra, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cempra, Inc. – Johnson & Johnson and Innoviva, Inc. (JNJ-US and INVA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 4.87 million, Net Earnings ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of CEMP earnings conference call or presentation 28-Apr-17 12:45pm GMT

    Q1 2017 Cempra Inc Earnings Call